Advanced search
Publication Cover
Scandinavian Cardiovascular Journal Volume 55, 2021 - Issue 2
Submit an article Journal homepage
2,599
Views
43
CrossRef citations to date
0
Altmetric
Original Articles

A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index

Murat Goka Cardiology Clinic, Edirne Sultan 1.Murat State Hospital, Edirne, TurkeyCorrespondence[email protected]
&
Alparslan Kurtulb Faculty of Medicine, Department of Cardiology, Hatay Mustafa Kemal University, Hatay, Turkey
Pages 91-96 | Received 07 Apr 2020, Accepted 31 Oct 2020, Published online: 02 Dec 2020

References

  • Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163(14):1711–1717.
  • Kucher N, Goldhaber SZ. Risk stratification of acute pulmonary embolism. Semin Thromb Hemost. 2006;32(8):838–847.
  • Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J. 2000;21(16):1301–1336.
  • Jiménez D, Kopecna D, Tapson V, et al. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J RespirCrit Care Med. 2014;189(6):718–726.
  • Abul Y, Karakurt S, Ozben B, et al. C-reactive protein in acute pulmonary embolism. J Investig Med. 2011;59(1):8–14.
  • Araz O, Yilmazel Ucar E, Yalcin A, et al. Predictive value of serum Hs-CRP levels for outcomes of pulmonary embolism. Clin Respir J. 2016;10(2):163–167.
  • Omar HR, Mirsaeidi M, Rashad R, et al. Association of serum albumin and severity of pulmonary embolism. Medicina. 2020;56(1):26.
  • Phan T, Brailovsky Y, Fareed J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict all-cause mortality in acute pulmonary embolism. Clin Appl Thromb Hemost. 2020;26:107602961990054.
  • Chung T, Connor D, Joseph J, et al. Platelet activation in acute pulmonary embolism. J Thromb Haemost. 2007;5(5):918–924.
  • Jo JY, Lee MY, Lee JW, et al. Leukocytes and systemic inflammatory response syndrome as prognostic factors in pulmonary embolism patients. BMC Pulm Med. 2013;13(1):74.
  • Ince LM, Weber J, Scheiermann C. Control of leukocyte trafficking by stress-associated hormones. Front Immunol. 2018;9:3143.
  • Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261–6272.
  • Diao P, Wu Y, Li J, et al. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. J Transl Med. 2018;16(1):365.
  • Jomrich G, Gruber ES, Winkler D, et al. Systemic Immune-Inflammation Index (SII) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg. 2020;24(3):610–618.
  • Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29(18):2276–2315.
  • Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129–138.
  • Cooper TJ, Prothero DL, Gillett MG, et al. Laboratory investigation in the diagnosis of pulmonary thromboembolism. Q J Med. 1992;83(301):369–379.
  • Perrier A, Bounameaux H. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost. 2001;86(07):475–487.
  • Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23):I22–I30.
  • Piazza G, Ridker PM. Is venous thromboembolism a chronic inflammatory disease? Clin Chem. 2015;61(2):313–316.
  • Piazza G, Goldhaber SZ. Venous thromboembolism and atherothrombosis: an integrated approach. Circulation. 2010;121(19):2146–2150.
  • Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol. 2016;99:272–285.
  • Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein and risk of venous thromboembolism in the general population. Arterioscler Thromb Vasc Biol. 2010;30(8):1672–1678.
  • Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116(4):427–433.
  • Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J. 2005;26(20):2166–2172.
  • Ng AC, Yong AS, Chow V, et al. Cardiac troponin-T and the prediction of acute and long-term mortality after acute pulmonary embolism. Int J Cardiol. 2013;165(1):126–133.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.